Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1 Wearing down a diagnosis
- Case 2 The woman who couldn’t handle her lips smacking any longer
- Case 3 The depressed bipolar patient on multiple medications
- Case 4 The agitated patient who finally wasn’t
- Case 5 The George who was not psychotic but anxious and distracted
- Case 6 The man who saw enemies everywhere
- Case 7 The young woman with psychosis complicated by substance use and a history of traumatic brain injury
- Case 8 The woman with worsening psychosis and a mysterious rash
- Case 9 The man without a plan
- Case 10 The anxious depressed woman who couldn’t sit still
- Case 11 The man who thinks it’s the end of the world
- Case 12 Sunny with a chance of depression
- Case 13 A not-so-simple case of anxiety
- Case 14 I’m a woman in a man’s body
- Case 15 The spacey, fidgety son with overwhelming sadness
- Case 16 The man who spent thousands online
- Case 17 The traumatized mother who can’t stop bingeing
- Case 18 The man who couldn’t stop hitting people
- Case 19 Brexpiprazole: “an awakening”
- Case 20 Treatment-resistant depression and opioid dependence
- Case 21 A stiff patient
- Case 22 An adolescent awakening
- Case 23 The peace keeper with a left breast mass
- Case 24 The girl who slept with problems
- Case 25 Not all child’s play: a path to pediatric stability
- Case 26 The young woman who was “nothing but skin and bones”
- Case 27 Could it be both? Comorbid psychiatric diagnoses
- Case 28 Treatment-emergent mania/hypomania in a depressed patient
- Case 29 The border between mood and personality
- Case 30 The student who wanted to go to rehab
- Case 31 The boy who wouldn’t (couldn’t) listen
- Case 32 The patient who went streaking
- Case 33 “Perseverance”
- Case 34 Clozapine (Clozaril) candidate discombobulates compassionate clinicians
- Index of drug names
- Index of case studies
- References
Case 25 - Not all child’s play: a path to pediatric stability
Published online by Cambridge University Press: 19 October 2021
Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1 Wearing down a diagnosis
- Case 2 The woman who couldn’t handle her lips smacking any longer
- Case 3 The depressed bipolar patient on multiple medications
- Case 4 The agitated patient who finally wasn’t
- Case 5 The George who was not psychotic but anxious and distracted
- Case 6 The man who saw enemies everywhere
- Case 7 The young woman with psychosis complicated by substance use and a history of traumatic brain injury
- Case 8 The woman with worsening psychosis and a mysterious rash
- Case 9 The man without a plan
- Case 10 The anxious depressed woman who couldn’t sit still
- Case 11 The man who thinks it’s the end of the world
- Case 12 Sunny with a chance of depression
- Case 13 A not-so-simple case of anxiety
- Case 14 I’m a woman in a man’s body
- Case 15 The spacey, fidgety son with overwhelming sadness
- Case 16 The man who spent thousands online
- Case 17 The traumatized mother who can’t stop bingeing
- Case 18 The man who couldn’t stop hitting people
- Case 19 Brexpiprazole: “an awakening”
- Case 20 Treatment-resistant depression and opioid dependence
- Case 21 A stiff patient
- Case 22 An adolescent awakening
- Case 23 The peace keeper with a left breast mass
- Case 24 The girl who slept with problems
- Case 25 Not all child’s play: a path to pediatric stability
- Case 26 The young woman who was “nothing but skin and bones”
- Case 27 Could it be both? Comorbid psychiatric diagnoses
- Case 28 Treatment-emergent mania/hypomania in a depressed patient
- Case 29 The border between mood and personality
- Case 30 The student who wanted to go to rehab
- Case 31 The boy who wouldn’t (couldn’t) listen
- Case 32 The patient who went streaking
- Case 33 “Perseverance”
- Case 34 Clozapine (Clozaril) candidate discombobulates compassionate clinicians
- Index of drug names
- Index of case studies
- References
Summary
Pretest self-assessment question (answer at the end of the case)
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential Psychopharmacology , pp. 291 - 306Publisher: Cambridge University PressPrint publication year: 2021
References
de Miranda, AS, de Miranda, AS, Teixeira, AL. Lamotrigine as a mood stabilizer: insights from the pre-clinical evidence. Expert Opinion on Drug Discovery 2019; 14:179–90, https://doi.org/10.1080/17460441.2019.1553951CrossRefGoogle Scholar
Biederman, J, Mick, E, Hammerness, P, et al. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biol Psychiatry 2005; 58: 589–94. https://doi.org/10.1016/j.biopsych.2005.03.019Google Scholar
Biederman, J, Joshi, G, Mick, E, et al. A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. CNS Neurosci Ther 2010; 16:91–102. https://doi.org/10.1111/j.1755-5949.2009.00121.xCrossRefGoogle ScholarPubMed
Carandang, C, Robbins, D, Mullany, E, et al. Lamotrigine in adolescent mood disorders: a retrospective chart review.J Can Acad Child Adolesc Psychiatry 2007; 16:1–8.Google ScholarPubMed
Cerullo, MA, Strakowski, SM. A systematic review of the evidence for the treatment of acute depression in bipolar I disorder. CNS Spectr 2013; 18:199–208. https://doi.org/10.1017/S1092852913000102Google Scholar
Connolly, KR, Thase, MD. The clinical management of bipolar disorder: a review of evidence-based guidelines. Prim Care Companion CNS Disord 2011; 13:PCC.10r0109. https://doi.org/10.4088/PCC.10r01097Google ScholarPubMed
DelBello, MP, Goldman, R, Phillips, D, et al. Efficacy and safety of lurasidone in children and adolescents with bipolar I depression: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 2017; 56:1015–25. https://doi.org/10.1016/j.jaac.2017.10.006CrossRefGoogle ScholarPubMed
Findling, RL., Landbloom, RL., Szegedi, A., et al. Asenapine for the acute treatment of pediatric manic or mixed episode of bipolar I disorder. J Am Acad Child Adolesc Psychiatry 2015; 54:1032–41. https://doi.org/10.1016/j.jaac.2015.09.007Google Scholar
Fountoulakis, KN, Kasper, S, Andreassen, O, et al. Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci. 2012; 262 (Suppl. 1): 1–48. https://doi.org/10.1007/s00406-012-0323-xCrossRefGoogle ScholarPubMed
Fountoulakis, KN, Kontis, D, Gonda, X, et al. Treatment of mixed bipolar states. Int J Neuropsychopharmacol. 2012; 15:1015–26. https://doi.org/10.1017/S1461145711001817CrossRefGoogle ScholarPubMed
Frazier, JA, Biederman, J, Tohen, M, et al. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2001; 11:239–50. https://doi.org/10.1089/10445460152595568Google Scholar
Fusar-Poli, P, Howes, O, Bechdolf, A, Borgwardt, S. Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies. J Psychiatry Neurosci 2012; 37:170–84. https://doi.org/10.1503/jpn.110061CrossRefGoogle ScholarPubMed
Goldberg, JF Bowden, CL Calabrese, JR et al. Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. Biol Psychiatry 2008; 63:125–30. https://doi.org/10.1016/j.biopsych.2006.12.031Google Scholar
Goodwin, GM, Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009; 23:346–88. https://doi.org/10.1177/0269881109102919Google Scholar
Lewitzka, U, Severus, E, Bauer, R, et al. The suicide prevention effect of lithium: more than 20 years of evidence – a narrative review. Int J Bipolar Disord 2015; 3:32. https://doi.org/10.1186/s40345-015-0032-2Google Scholar
Musetti, L, Del Grande, C, Marazziti, D, Dell’Osso, L. Treatment of bipolar depression. CNS Spectr 2013; 18:177–87. https://doi.org/10.1017/S1092852912001009Google Scholar
Pavuluri, MN, Henry, DB, Moss, M, et al. Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder. J Child Adolesc Psychopharmacol 2009; 19:75–82. https://doi.org/10.1089/cap.2008.0107Google Scholar
Praharaj, SK, Jana, AK, Goyal, N, Sinha, VK. Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis. Br J Clin Pharmacol 2011; 71:377–82. https://doi.org/10.1111/j.1365-2125.2010.03783.xGoogle Scholar
Stahl, SM. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 4th edn. New York, NY: Cambridge University Press, 2013.Google Scholar
Stahl, SM. Stahl’s Essential Psychopharmacology: Prescriber’s Guide, 5th edn. New York, NY: Cambridge University Press, 2014.Google Scholar
Tohen, M, Kryzhanovskaya, L, Carlson, G, et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 2007; 164:1547–56. https://doi.org/10.1176/appi.ajp.2007.06111932Google Scholar
Vázquez, M, Maldonado, C, Guevara, N, et al. Lamotrigine–valproic acid interaction leading to Stevens–Johnson syndrome. Case Rep Med 2018; 2018:5371854. https://doi.org/10.1155/2018/5371854Google Scholar